Sun Pharmaceutical in talks to buy Sweden’s Meda AB for $5-6 bn

A spokeswoman for Sun Pharma,which has a market value of roughly $20 bn,declined to comment.

Written by Reuters | Published: May 31, 2013 6:13 pm

Sun Pharmaceutical Industries is in talks to buy a controlling stake in Swedish drugmaker Meda AB for between $5 billion and $6 billion to boost its generics business in developed markets,two sources with direct knowledge of the matter said.


STOCK MARKETS LINKS

* BSE

Sensex

* NSE

Nifty

* Top Gainers/Top

Losers

* Top

Value

* Top

Quantity

* Best Performing Mutual

Funds


Meda makes specialty products,over the counter drugs and branded generics – the same areas of focus as Sun Pharma.

Mumbai-based Sun Pharma is India’s most valuable drugmaker and has made a series of acquisitions in the past.

It is in talks with a clutch of banks to raise funds for a possible deal,the sources said,declining to be identified because the talks are not public.

A spokeswoman for Sun Pharma,which has a market value of roughly $20 billion,declined to comment. Meda AB was not immediately available for comment.

For all the latest News Archive News, download Indian Express App

    Live Cricket Scores & Results